MEGHAN GUNNESS: Open Payments
NPI 1710578877 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 21 payments from 7 companies in 2025. Trend: 2023 $374 · 2024 $347 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $168 |
| Astellas Pharma US Inc | 4 | $103 |
| Daiichi Sankyo Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $53 |
| Boston Scientific Corporation | 1 | $26 |
| PFIZER INC. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Veozah, INJECTAFER, WATCHMAN FLX, QULIPTA, CREON, NURTEC ODT, VRAYLAR.
Industry payments across LA — which companies pay providers there.
